Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 17 | 2019 | 1143 | 1.560 |
Why?
|
| Leukoaraiosis | 7 | 2019 | 45 | 1.160 |
Why?
|
| Brain Ischemia | 8 | 2019 | 402 | 0.680 |
Why?
|
| Cerebral Hemorrhage | 4 | 2017 | 89 | 0.540 |
Why?
|
| Headache | 2 | 2013 | 63 | 0.440 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2014 | 72 | 0.420 |
Why?
|
| Migraine Disorders | 1 | 2013 | 45 | 0.410 |
Why?
|
| Thrombolytic Therapy | 4 | 2019 | 182 | 0.400 |
Why?
|
| Fibrinolytic Agents | 2 | 2013 | 164 | 0.360 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2010 | 3 | 0.350 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2010 | 15 | 0.340 |
Why?
|
| Connective Tissue | 1 | 2010 | 12 | 0.340 |
Why?
|
| Vertebral Artery Dissection | 1 | 2010 | 13 | 0.340 |
Why?
|
| Retrospective Studies | 19 | 2019 | 6040 | 0.310 |
Why?
|
| Aged, 80 and over | 15 | 2019 | 5149 | 0.280 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2007 | 20 | 0.280 |
Why?
|
| Dystonia | 1 | 2007 | 13 | 0.280 |
Why?
|
| Dexmedetomidine | 1 | 2007 | 8 | 0.280 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2007 | 19 | 0.280 |
Why?
|
| Critical Care | 1 | 2011 | 415 | 0.270 |
Why?
|
| Recovery of Function | 4 | 2019 | 264 | 0.270 |
Why?
|
| White Matter | 2 | 2019 | 114 | 0.270 |
Why?
|
| Endovascular Procedures | 5 | 2017 | 575 | 0.270 |
Why?
|
| Brain | 3 | 2017 | 1492 | 0.250 |
Why?
|
| Risk Factors | 11 | 2019 | 5040 | 0.250 |
Why?
|
| Aged | 20 | 2019 | 13461 | 0.240 |
Why?
|
| Brain Injuries | 1 | 2007 | 137 | 0.240 |
Why?
|
| Atrial Fibrillation | 3 | 2018 | 801 | 0.240 |
Why?
|
| Severity of Illness Index | 7 | 2019 | 1460 | 0.230 |
Why?
|
| Cerebrum | 2 | 2015 | 16 | 0.220 |
Why?
|
| Male | 22 | 2019 | 27769 | 0.210 |
Why?
|
| Middle Aged | 17 | 2019 | 16401 | 0.210 |
Why?
|
| Humans | 28 | 2019 | 59816 | 0.200 |
Why?
|
| Female | 21 | 2019 | 31098 | 0.180 |
Why?
|
| Cerebral Angiography | 5 | 2014 | 283 | 0.180 |
Why?
|
| Treatment Outcome | 9 | 2019 | 5205 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2019 | 2049 | 0.170 |
Why?
|
| Bed Rest | 1 | 2019 | 9 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2015 | 1470 | 0.170 |
Why?
|
| Cerebral Infarction | 3 | 2016 | 75 | 0.170 |
Why?
|
| Vitamin K | 1 | 2019 | 17 | 0.170 |
Why?
|
| Mechanical Thrombolysis | 1 | 2019 | 35 | 0.160 |
Why?
|
| Intracranial Hemorrhages | 1 | 2019 | 62 | 0.160 |
Why?
|
| Hematoma | 1 | 2019 | 74 | 0.160 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2010 | 181 | 0.160 |
Why?
|
| Leukoencephalopathies | 1 | 2019 | 24 | 0.160 |
Why?
|
| Time-to-Treatment | 2 | 2016 | 100 | 0.150 |
Why?
|
| Ischemic Attack, Transient | 1 | 2019 | 91 | 0.150 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2016 | 141 | 0.140 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2018 | 160 | 0.140 |
Why?
|
| Prognosis | 4 | 2018 | 1584 | 0.140 |
Why?
|
| Stroke Volume | 1 | 2018 | 321 | 0.140 |
Why?
|
| Ventricular Function, Left | 1 | 2018 | 264 | 0.140 |
Why?
|
| Eligibility Determination | 1 | 2016 | 34 | 0.130 |
Why?
|
| Neuroimaging | 2 | 2016 | 131 | 0.130 |
Why?
|
| Patient Transfer | 2 | 2016 | 91 | 0.130 |
Why?
|
| Embolism | 1 | 2016 | 38 | 0.130 |
Why?
|
| Stroke, Lacunar | 1 | 2015 | 3 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 1030 | 0.120 |
Why?
|
| Thrombophilia | 1 | 2015 | 15 | 0.120 |
Why?
|
| Anticoagulants | 1 | 2019 | 485 | 0.120 |
Why?
|
| Embolism, Paradoxical | 1 | 2015 | 14 | 0.120 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2015 | 113 | 0.120 |
Why?
|
| Foramen Ovale, Patent | 1 | 2015 | 13 | 0.120 |
Why?
|
| Vitamin D Deficiency | 1 | 2015 | 50 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 99 | 0.110 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 107 | 0.110 |
Why?
|
| Patient Selection | 1 | 2016 | 448 | 0.110 |
Why?
|
| Heart Diseases | 1 | 2016 | 204 | 0.110 |
Why?
|
| Vitamin D | 1 | 2015 | 149 | 0.110 |
Why?
|
| Length of Stay | 1 | 2017 | 771 | 0.110 |
Why?
|
| Apraxias | 1 | 2013 | 7 | 0.110 |
Why?
|
| Speech Disorders | 1 | 2013 | 17 | 0.110 |
Why?
|
| ROC Curve | 1 | 2014 | 258 | 0.110 |
Why?
|
| Frontal Lobe | 1 | 2013 | 66 | 0.100 |
Why?
|
| Regression Analysis | 1 | 2014 | 486 | 0.100 |
Why?
|
| Air Ambulances | 1 | 2013 | 26 | 0.100 |
Why?
|
| Multivariate Analysis | 4 | 2017 | 925 | 0.100 |
Why?
|
| Cerebrovascular Disorders | 1 | 2013 | 74 | 0.100 |
Why?
|
| Risk Assessment | 5 | 2018 | 1918 | 0.100 |
Why?
|
| Adult | 8 | 2019 | 15882 | 0.100 |
Why?
|
| Logistic Models | 4 | 2017 | 1252 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 2014 | 309 | 0.090 |
Why?
|
| International Cooperation | 1 | 2011 | 81 | 0.090 |
Why?
|
| Heart Failure | 1 | 2018 | 868 | 0.090 |
Why?
|
| Gastrostomy | 1 | 2010 | 33 | 0.090 |
Why?
|
| Deglutition Disorders | 1 | 2010 | 43 | 0.090 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2010 | 10 | 0.090 |
Why?
|
| Enteral Nutrition | 1 | 2010 | 56 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 638 | 0.090 |
Why?
|
| Disability Evaluation | 3 | 2018 | 216 | 0.090 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2009 | 5 | 0.090 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2009 | 30 | 0.080 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2010 | 117 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1037 | 0.080 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2010 | 92 | 0.080 |
Why?
|
| Sympathetic Nervous System | 1 | 2008 | 33 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 909 | 0.070 |
Why?
|
| Chest Pain | 1 | 2008 | 84 | 0.070 |
Why?
|
| Time Factors | 3 | 2019 | 3590 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 709 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 253 | 0.070 |
Why?
|
| Odds Ratio | 3 | 2016 | 773 | 0.070 |
Why?
|
| Heart | 1 | 2008 | 276 | 0.060 |
Why?
|
| Linear Models | 2 | 2017 | 423 | 0.060 |
Why?
|
| Animals | 2 | 2013 | 19719 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 402 | 0.060 |
Why?
|
| Intracranial Aneurysm | 1 | 2008 | 343 | 0.050 |
Why?
|
| Registries | 2 | 2016 | 804 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2019 | 2461 | 0.050 |
Why?
|
| Neurologic Examination | 1 | 2019 | 51 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 344 | 0.040 |
Why?
|
| Radiography | 1 | 2019 | 513 | 0.040 |
Why?
|
| Triage | 1 | 2017 | 111 | 0.030 |
Why?
|
| Plasminogen Activators | 1 | 2015 | 10 | 0.030 |
Why?
|
| Echocardiography | 1 | 2018 | 459 | 0.030 |
Why?
|
| Patient Admission | 1 | 2017 | 185 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 207 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 1098 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 553 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2015 | 155 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 577 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 1559 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2017 | 251 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2017 | 452 | 0.030 |
Why?
|
| Rural Health Services | 1 | 2013 | 30 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 1052 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2013 | 125 | 0.020 |
Why?
|
| Acute Disease | 1 | 2013 | 659 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 1288 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2341 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 1205 | 0.020 |
Why?
|
| Medical Records | 1 | 2010 | 139 | 0.020 |
Why?
|
| Boston | 1 | 2010 | 333 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1527 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2008 | 41 | 0.020 |
Why?
|
| Middle Cerebral Artery | 1 | 2008 | 46 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 1843 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2008 | 94 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 2008 | 245 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2008 | 524 | 0.010 |
Why?
|
| Child | 1 | 2013 | 4324 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 4365 | 0.010 |
Why?
|
| United States | 1 | 2015 | 7570 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 3110 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 5939 | 0.010 |
Why?
|